← Back to Search

Behavioral Intervention

Mindfulness-Based Cognitive Therapy for Depression Relapse Prevention (HMHL Trial)

N/A
Recruiting
Led By Linda Ko, MPH,PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

HMHL Trial Summary

This trial will test if a brief version of mindfulness-based therapy delivered by telephone can help prevent depression relapse and reduce symptoms in older Korean Americans.

Who is the study for?
This trial is for older Korean Americans aged 55-89 with mild to moderate depression, who speak Korean fluently but have limited English skills. They must not have major psychiatric diseases, severe medical conditions, or a history of mindfulness training. Participants should be able to consent and commit to the study.Check my eligibility
What is being tested?
The trial tests a telephone-delivered version of Mindfulness-Based Cognitive Therapy (MBCT) tailored for older Korean Americans. It aims to see if this brief MBCT can reduce depressive symptoms and prevent relapse in this specific population.See study design
What are the potential side effects?
Since MBCT involves mental exercises like meditation, side effects may include temporary increases in emotional discomfort as participants become more aware of their thoughts and feelings.

HMHL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Depression
Secondary outcome measures
Sleep

HMHL Trial Design

1Treatment groups
Experimental Treatment
Group I: Group-based MBCTExperimental Treatment1 Intervention
A telephone-based, 8-week MBCT session including: (1) learning mindfulness skills; (2) practicing mindfulness skills in class and at home; and (3) dialogue and inquiry.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,741 Previous Clinical Trials
1,847,720 Total Patients Enrolled
Asian American Resource and Information Network, Inc (AARIN)UNKNOWN
Linda Ko, MPH,PhDPrincipal InvestigatorUniversity of Washington

Media Library

Healthy Mind, Healthy Living (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05965349 — N/A
Depression and Anxiety Research Study Groups: Group-based MBCT
Depression and Anxiety Clinical Trial 2023: Healthy Mind, Healthy Living Highlights & Side Effects. Trial Name: NCT05965349 — N/A
Healthy Mind, Healthy Living (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05965349 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What prerequisites must potential participants fulfill to take part in this experiment?

"Qualified applicants for this trial need to meet two criteria: have a diagnosis of depression and fit into the age range of 50-89. This research is expected to recruit 40 participants in total."

Answered by AI

Is enrollment now available for this clinical trial?

"As per clinicaltrials.gov, this medical trial is accepting participants at the moment. The first posting of it was on April 3rd 2023 and the most recent edition occurred on July 19th 2023."

Answered by AI

What is the total cohort size of this clinical trial?

"Absolutely. According to clinicaltrials.gov, the study is still looking for individuals to take part in it; this initiative was first published on April 3rd 2023 and its details were updated July 19th of the same year. 40 participants are needed from a single location."

Answered by AI

Is the participation of minors in this research endeavor encouraged?

"As specified by the criteria for admission, participants must be between 50 and 89 years old. For individuals under 18 or over 65 respectively, there are 245 clinical trials available and 1077 studies to choose from."

Answered by AI
~20 spots leftby Apr 2025